Reported Reactions

Devices › Device types

FDA product code NPU · class 3 · Unknown

Prosthesis, mitral valve, percutaneously delivered: medical device reports filed with FDA

1,972 reports carry this product code, 2017–2026; 28 brands with a page.

1,972
reports with this product code
0% of all MAUDE reports
469
reports, 12 months to August 2026
244 in the 12 months before
7.1%
classified as malfunction
62.3% across all reports
21.1%
classified as death, as reported
0.9% across all reports

Product code NPU is FDA's classification for "Prosthesis, mitral valve, percutaneously delivered" (unknown panel), a class 3 device. 1,972 medical device reports carry this product code, 0% of the MAUDE database, from May 2017 to August 2026.

469 reports arrived in the 12 months to August 2026, up 92% from 244 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (71.8%), death (21.1%) and malfunction (7.1%). 28 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Edwards SAPIEN 3 Transcatheter Heart valve3586689.2%2.2%
Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve2121,12811.6%4.8%
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve18771414%8.1%
Edwards COMMANDER DELIVERY SYSTEM18336812.3%46.3%
SAPIEN 3 Transcatheter Heart Valve1164196%1%
Edwards SAPIEN 3 Transcatheter Heath Valve886714.9%1.7%
Commander Delivery System7530610.6%47.4%
Edwards eSheath Introducer Set55159.7%35.8%
Edwards Sapien 3 Transcatheter28836.5%2%
Edwards Lifesciences SAPIEN 3 Transcatheter Heart Valve201325.3%1.5%
Sapien 3 Ultra Resilia Transcatheter Heart Valve167110.3%8.6%
Edwards Lifesciences SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve142273.4%4.2%
Edwards Commander Delivery12412.3%48.6%
Edwards Sapien 3 Ultra Transcatheter Heart Valve System11898.3%12.2%
Sapien 3 Ultra Transcatheter Heart Valve11776.6%8.3%
Edwards Sapien 3 Ultra8229.6%7.3%
Edwards SAPIEN XT Transcatheter Heart Valve8487.6%2.4%
Edwards Lifesciences Commander Delivery System712410.3%50%
Edwards Sapien 3 Ultra Valve7138.9%23.8%
Edwards Sapien Transcatheter Heart Valve7714.3%2.9%
Edwards Certitude Delivery System4205.1%55.4%
Edwards Sapien 3 Transcatheter Heart Valve 26mm4015.7%4.4%
Edwards SAPIEN 3 Ultra RESILIA valve21016.5%6.5%
Carpentier-Edwards PERIMOUNT Magna Mitral Ease Pericardial Bioprosthesis12331%1.4%
Edwards Expandable Introducer Sheath Set102.9%18.8%
Edwards Lifesciences SAPIEN 3 Ultra Transcatheter Heart Valve11356.9%4.1%
Edwards Sapien 3 Transcatheter Heart Valve Thv104.4%2.2%
Edwards Transfemoral Esheath Unknown1944.6%0%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Edwards Lifesciences1,90996.8%

Reports by month, five years

03161Sep 2021: 28Oct 2021: 42Nov 2021: 12Dec 2021: 132022Jan 2022: 30Feb 2022: 6Mar 2022: 4Apr 2022: 29May 2022: 12Jun 2022: 5Jul 2022: 29Aug 2022: 11Sep 2022: 11Oct 2022: 30Nov 2022: 5Dec 2022: 412023Jan 2023: 9Feb 2023: 19Mar 2023: 44Apr 2023: 13May 2023: 19Jun 2023: 38Jul 2023: 11Aug 2023: 16Sep 2023: 6Oct 2023: 49Nov 2023: 16Dec 2023: 482024Jan 2024: 11Feb 2024: 8Mar 2024: 41Apr 2024: 17May 2024: 19Jun 2024: 47Jul 2024: 11Aug 2024: 46Sep 2024: 16Oct 2024: 14Nov 2024: 11Dec 2024: 392025Jan 2025: 8Feb 2025: 12Mar 2025: 39Apr 2025: 12May 2025: 26Jun 2025: 36Jul 2025: 19Aug 2025: 12Sep 2025: 25Oct 2025: 49Nov 2025: 16Dec 2025: 612026Jan 2026: 19Feb 2026: 44Mar 2026: 59Apr 2026: 38May 2026: 40Jun 2026: 36Jul 2026: 40Aug 2026: 42

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death21.1%417
Injury71.8%1,415
Malfunction7.1%140
Other0%0
Not given0%0

Who filed

Manufacturer report97.7%1,927
Voluntary report0.8%15
User facility report0%0
Distributor report0%0
Not given1.5%30

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Insufficient device problem information33517%
Perivalvular leak27413.9%
Malposition of device1387%
Fluid/blood leak1065.4%
Device stenosis673.4%
Patient device interaction problem653.3%
Migration or expulsion of device643.2%
Difficult to open or close512.6%
Degraded502.5%
Difficult to removethe device was hard to remove452.3%
Gradient increase452.3%
Migrationthe device moved from where it was placed442.2%
Burst container or vessel432.2%
Calcified331.7%
Device dislodged or dislocated331.7%
Intravalvular regurgitation321.6%
Incomplete coaptation251.3%
Material deformation180.9%
Material split, cut or torn160.8%
Material rupture150.8%

Questions about prosthesis, mitral valve, percutaneously delivered reports

What is product code NPU?

FDA's classification code for "Prosthesis, mitral valve, percutaneously delivered", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.

How many reports carry this code?

1,972 reports through August 2026, 469 of them in the latest 12 months.

Which brands appear most often?

Edwards SAPIEN 3 Transcatheter Heart valve (358), Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve (212), Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (187), Edwards COMMANDER DELIVERY SYSTEM (183) and SAPIEN 3 Transcatheter Heart Valve (116). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.